DHA sbir sequential medical research and development phase II contract titled: agitube (now CLR),"further studies to refine device use for the management of hemothorax and other pleural collections"…
Active Definitive Contract Awarded Last action
- Contract number
- HT942524C0010
- Awardee
-
Innovital Systems Inc. UEI K9LTGEA4MVS5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,300,000
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $1,300,000.00 Current and potential, with all options
- Completion date 84% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Calverton, MD 20705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,300,000 |
About this award
The Defense Health Agency (DHA) awarded a $1.3 million Small Business Innovation Research (SBIR) Phase II contract to Innovital Systems Inc. on January 5, 2024, for continued development of the CLR device (formerly AGITUBE), which is designed to refine device use for managing hemothorax and other pleural collections. This total small business set-aside contract carries a firm fixed price structure with an ultimate completion date of May 4, 2027, and will be performed in Calverton, Maryland, where the awardee is headquartered.
Innovital Systems Inc. is a small, advanced technology company with extensive experience delivering specialized medical device development through the SBIR program for multiple Department of Defense agencies. The company's track record includes developing innovative combat and emergency medical technologies such as next-generation airways, transport systems, and intubation devices. This Phase II award builds on the company's established expertise in biomedical engineering and represents continued federal investment in refining medical technologies that address critical battlefield and trauma care needs related to pleural complications.
Description
DHA sbir sequential medical research and development phase II contract titled: agitube (now CLR),"further studies to refine device use for the management of hemothorax and other pleural collections" please note CLR is not an abbreviation.
Quick answers
Who was awarded contract HT942524C0010?
HT942524C0010 was awarded to Innovital Systems Inc. by Defense Health Agency (Department of Defense) on January 5, 2024.
How much is contract HT942524C0010 worth?
The government has obligated $1,300,000 on HT942524C0010.
Was contract HT942524C0010 competed?
The extent of competition for HT942524C0010 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award